Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells

Experimental Cell Research

Volumn 319, Issue 10, 2013, Pages 1534-1543

  Duncan, Henry F ^a   Smith, Anthony J ^b   Fleming, Garry J P ^a   Cooper, Paul R ^b  

^a DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cell differentiation; Cell viability; Epigenetics; Histone deacetylase inhibitor; Pulp; Regeneration

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CASPASE 3; DENTIN MATRIX PROTEIN 1; DSPP PROTEIN; HISTONE DEACETYLASE INHIBITOR; MEMBRANE PROTEIN; NESTIN; OSTEOPONTIN; PROTEIN P21; PROTEIN P53; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL GROWTH; CELL REGENERATION; CELL VIABILITY; CELLS; CONTROLLED STUDY; CYTOTOXICITY; DENTAL PULP CELL; ENZYME ACTIVITY; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION; MALE; MINERALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOOTH DEVELOPMENT;

EID: 84877926530     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.02.022     Document Type: Article

References (39)

1. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
2. Yang X.J., Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007, 26:5310-5318.
3. Balasubramanian S., Verner E., Buggy J.J. Isoform-specific histone deacetylase inhibitors: the next step?. Cancer Lett. 2009, 280:211-221.
4. Schroeder T.M., Westendorf J.J. Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res. 2005, 20:2254-2263.
5. Marks P.A Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular function. Biochim. Biophys. Acta 2010, 1799:717-725.
6. Kretsovali A., Hadjimichael C., Charmpilas N. Histone deacetylase inhibitors in cell pluripotency, differentiation and reprogramming. Stem Cells Int. 2012, 2012:184154.
7. Leoni F., Fossati G., Lewis E.C., Lee J.K., Porro G., Pagani P., Modena D., Moras M.L., Pozzi P., Reznikov L.L, Siegmund B., Fantuzzi G., Dinarello C.A., Mascagni P. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol. Med. 2005, 11:1-15.
8. Ferracane J.L., Cooper P.R., Smith A.J. Can interaction of materials with the dentin-pulp complex contribute to dentin regeneration?. Odontology 2010, 98:2-14.
9. Duncan H.F., Smith A.J., Fleming G.J.P., Cooper P.R. HDACi: cellular effects, opportunities for restorative dentistry. J. Dent. Res. 2011, 12:1377-1388.
10. Simon S., Perard M., Zanini M M., Smith A.J., Charpentier E., Djole S.X., Lumley P.J. Should pulp chamber pulpotomy be seen as a permanent treatment? Some preliminary thoughts. Int. Endod. J. 2013, 46:79-87.
11. Barthel C.R., Rosenkranz B., Leuenberg A., Roulet J.F. Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study. J. Endod. 2000, 26:525-528.
12. Cooper P.R., Takahashi Y., Graham L.W., Simon S., Imazato S., Smith A.J. Inflammation-regeneration interplay in the dentine-pulp complex. J. Dent. 2010, 38:687-697.
13. Cox C.F., Sübay R.K., Ostro E., Suzuki S., Suzuki S.H. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper. Dent. 1996, 21:4-11.
14. Tran X.V., Gorin C., Willig C., Baroukh B., Pellat B., Decup F., Opsahl Vital S., Chaussain C., Boukpessi T. Effect of a calcium-silicate-based restorative cement on pulp repair. J. Dent. Res. 2012, 91:1166-1171.
15. Duncan H.F., Smith A.J., Fleming G.J.P., Cooper P.R. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. J. Endod. 2012, 38:339-345.
16. Kwon A., Park H.J., Baek K., Lee H.L., Park J.C., Woo K.M., Ryoo H.M., Baek J.H. Suberoylanilide hydroxamic acid enhances odontoblast differentiation. J. Dent. Res. 2012, 91:506-512.
17. Ungerstedt J.S., Sowa Y., Xu W.S., Shao Y., Dokmanovic M., Perez G., Ngo L., Holmgren A., Jiang X., Marks P.A. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 2005, 102:673-678.
18. Lee J.H., Choy M.L., Ngo L., Foster S.S., Marks P.A. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc. Natl. Acad. Sci. USA 2010, 107:14639-14644.
19. Rosato R.R., Maggio S.C., Almenara J.A., Payne S.G., Atadja P., Spiegel S., Dent P., Grant S. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. Mol. Pharmacol. 2006, 69:216-225.
20. Eriksson I., Joosten M., Roberg K., Öllinger K. The histone deacetylase inhibitor trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis. Exp. Cell. Res 2013, 319:12-20.
21. Lee J.H., Choy M.L., Marks P.A. Mechanisms of resistance to histone deacetylase inhibitors. Adv. Cancer Res. 2012, 116:39-86.
22. Elaut G., Rogiers V., Vanhaecke T. The pharmaceutical potential of histone deacetylase inhibitors. Curr. Pharm. Des. 2007, 13:2584-2620.
23. Patel M., Smith A.J., Sloan A.J., Smith G., Cooper P.R. Phenotype and behavior of dental pulp cells during expansion culture. Arch. Oral Biol. 2009, 54:898-908.
24. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 2004, 329:77-84.
25. WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 2004, 101:1241-1246.
26. WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. USA 2000, 97:10014-10019.
27. Cho H.H., Park H.T., Kim Y.J., Bae Y.C., Suh K.T., Jung J.S. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylease inhibitors. J. Cell. Biochem. 2005, 96:533-542.
28. Sakata R., Minami S., Sowa Y., Yoshida M., Tamaki T. Trichostatin A activates the osteopontin gene promoter through AP1 site. Biochem. Biophys. Res. Commun. 2004, 315:959-963.
29. Czekanska E.M., Stoddart M.J. In search of an osteoblast cell model for in vitro research. Eur. Cell Mater. 2012, 4:1-17.
30. Hanks C.T., Sun Z.L., Fang D.N., Edwards C.A., Wataha J.C., Ritchie H.H, Butler W.T Cloned 3T6 cell line from CD-1 mouse fetal molar dental papillae. Connect. Tissue Res. 1998, 37:233-249.
31. Goldberg M., Smith A.J. Cells and extracellular matrices of dentin and pulp: a biological basis for repair and tissue engineering. Crit. Rev. Oral Biol. Med. 2004, 15:13-27.
32. Stringa E., Filanti C., Giunciuglio D., Albini A., Manduca P. Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. Bone 1995, 16:663-670.
33. Takuma S., Nagai N. Ultrastructure of rat odontoblasts in various stages of their development and maturation. Arch. Oral Biol. 1971, 16:993-1011.
34. Voegele T.J., Voegele-Kadletz M., Esposito V., Macfelda K., Oberndorfer U., Vecsei V., Schabus R. The effect of different isolation techniques on human osteoblast-like cell growth. Anticancer Res. 2000, 20:3575-3581.
35. Fortson W.S., Kayarthodi S., Fujimura Y., Xu H., Matthews R., Grizzle W.E., Rao V.N., Bhat G.K., Reddy E.S.P. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostrate cancer patients. Int. J. Oncol. 2011, 39:111-119.
36. Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., Smyth M.J., Johnstone R.W. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Natl. Acad. Sci. USA 2001, 98:10833-10838.
37. Fernandez-Capetillo O., Nussenzweig A. Linking histone deacetylation with the repair of DNA breaks. Proc. Natl. Acad. Sci. USA 2004, 101:1427-1428.
38. Schweikl H., Spagnuolo G., Schmalz G. Genetic and cellular toxicology of dental resin monomers. J. Dent. Res. 2006, 85:870-877.
39. Paranjpe A., Snug E.C., Cacalano N.A., Hume W.R., Jewett A. N-acetyl cysteine protects pulp cells from resin toxins in vivo. J. Dent. Res. 2008, 87:537-541.